Recurrent Non-small Cell Lung Cancer Withdrawn Phase 2 Trials for Pemetrexed (DB00642)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Withdrawn2 IdentifierTitlePurposeDrugs
NCT01928160Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibTreatment